September 16, 2022 Test Can ID Patients at Risk for Severe COVID-19, Study Suggests

A genomic test being developed by a Charlottesville company can predict a patient’s risk of developing severe COVID-19, new research from UVA Health suggests. That information could help doctors identify patients at high risk for poor outcomes and quickly begin tailored treatment. 

August 11, 2022 Eczema Treatment Cuts Risk of Death From COVID-19

A monoclonal antibody used to treat asthma and eczema can improve survival for patients with moderate to severe COVID-19, a clinical trial at UVA Health suggests.

June 22, 2022 UVA Health Providing COVID Vaccines June 25 for Children Ages 6 Months-4 Years Old

UVA Health is now scheduling appointments for the Pfizer COVID-19 vaccine for all children ages 6 months through 4 years…

April 14, 2022 Study Tracks COVID-19 Antibodies Over Time

A new study of COVID-19 antibodies shows that Pfizer vaccine antibodies fall faster than Moderna – and for Pfizer recipients, age matters.

February 21, 2022 UVA Health Joins National Trial Testing Medications for Mild-to-Moderate COVID-19

UVA Health has joined a nationwide study evaluating two repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19.

November 11, 2021 Drug Tested at UVA Offers Lasting COVID-19 Protection

The antibody cocktail reduced the risk of COVID-19 infection by more than 80% for more than eight months, Regeneron Pharmaceuticals announced.

November 3, 2021 UVA Health Scheduling COVID-19 Vaccine Appointments for 5-11 Year Olds

UVA Health is now scheduling appointments for the Pfizer COVID-19 vaccine for children 5-11 years old at its Pediatric Community Vaccination Center, with the first appointments available Monday, Nov. 8. 

October 25, 2021 Rural Areas, Hit Hard by COVID-19, Lack Access to New Treatment Trials

Three-quarters of rural Americans live more than an hour from the nearest site testing new treatments for COVID-19, new research reveals.

October 15, 2021 UVA Health Offering Booster, 3rd Doses of COVID-19 Vaccines

UVA Health will offer booster doses of the Pfizer COVID-19 vaccine and third doses of the Pfizer and Moderna vaccines for the immunocompromised beginning…

September 2, 2021 COVID-19 Study Quantifies Antibody Response to Pfizer, Moderna Vaccines

Antibody levels in recipients of the Moderna vaccine were slightly higher than in recipients of Pfizer.